Current Status and Future Directions of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer

被引：46
作者：
Helm, C. William [1 ]
机构：
[1] St Louis Univ, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, St Louis, MO 63117 USA
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2012年 / 21卷 / 04期
关键词：
Ovarian cancer; Epithelial ovarian cancer; Intraperitoneal chemotherapy; HIPEC; Hyperthermia; Hyperthermic intraperitoneal chemotherapy; GYNECOLOGIC-ONCOLOGY-GROUP; PEGYLATED LIPOSOMAL DOXORUBICIN; LONG-TERM SURVIVAL; DNA DAMAGE RESPONSES; PHASE-II TRIAL; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY; STAGE-III; FOLLOW-UP; SECONDARY CYTOREDUCTION;
D O I：
10.1016/j.soc.2012.07.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Epithelial ovarian cancer is a peritoneal surface malignancy that most often presents with spread of disease within the peritoneal cavity. Overall 5-year survival is around 50% and progress in improving outcomes is slow. Among other areas of research, hyperthermic intraperitoneal chemotherapy (HIPEC) provides a promising option. This article reviews the current status of treatment of epithelial ovarian cancer, experience with HIPEC to date, and future directions.
引用
收藏
页码：645 / +
页数：20
相关论文
共 50 条
[31]   Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer [J].
Lei, Ziying ;
Wang, Yue ;
Wang, Jiahong ;
Wang, Ke ;
Tian, Jun ;
Zhao, Ying ;
Chen, Lipai ;
Wang, Jin ;
Luo, Jiali ;
Jia, Manman ;
Tang, Hongsheng ;
He, Qingjun ;
Liao, Quanxing ;
Yang, Xiansheng ;
Guan, Tianpei ;
Wang, Li ;
Cui, Shuzhong .
JAMA NETWORK OPEN, 2020, 3 (08) :E2013940
[32]   Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer [J].
Ba, Mingchen ;
Long, Hui ;
Zhang, Xiangliang ;
Tang, Yunqiang ;
Wu, Yinbing ;
Wang, Shuai ;
Yan, Zhaofei ;
Zhang, Bohuo ;
Cui, Shuzhong .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (09) :1571-1579
[33]   Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States [J].
Charo, Lindsey M. ;
Jou, Jessica ;
Binder, Pratibha ;
Hohmann, Samuel F. ;
Saenz, Cheryl ;
McHale, Michael ;
Eskander, Ramez N. ;
Plaxe, Steven .
GYNECOLOGIC ONCOLOGY, 2020, 159 (03) :681-686
[34]   Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [J].
Riggs, McKayla J. ;
Pandalai, Prakash K. ;
Kim, Joseph ;
Dietrich, Charles S. .
DIAGNOSTICS, 2020, 10 (01)
[35]   Efficacy of hyperthermic intraperitoneal chemotherapy plus cytoreductive surgery for advanced or recurrent ovarian cancer: a systematic evaluation and meta-analysis [J].
Li, H. ;
Liao, L. -J. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (17) :8135-8143
[36]   Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study [J].
Deraco, M. ;
Virzi, S. ;
Iusco, D. R. ;
Puccio, F. ;
Macri, A. ;
Famulari, C. ;
Solazzo, M. ;
Bonomi, S. ;
Grassi, A. ;
Baratti, D. ;
Kusamura, S. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (07) :800-809
[37]   Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer [J].
Cascales Campos, P. ;
Gil, Jose ;
Parrilla, Pascual .
EJSO, 2014, 40 (08) :970-975
[38]   Role of surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer [J].
Kim, S., I ;
Kim, J-W .
ESMO OPEN, 2021, 6 (03)
[39]   It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer [J].
Zivanovic, Oliver ;
Chi, Dennis S. ;
Filippova, Olga ;
Randall, Leslie M. ;
Bristow, Robert E. ;
O'Cearbhaill, Roisin E. .
GYNECOLOGIC ONCOLOGY, 2018, 151 (03) :555-561
[40]   Secondary cytoreductive surgery, hyperthermic intraperitoneal intraoperative chemotherapy, and chemotherapy alone: a retrospective comparison of alternative approaches in relapsed platinum sensitive ovarian cancer [J].
Marocco, F. ;
Vaira, M. ;
Milani, A. ;
Genta, S. ;
Maggiorotto, F. ;
Magistris, A. ;
Cinquegrana, A. ;
Robella, M. ;
De Simone, M. ;
Aglietta, M. ;
Ponzone, R. ;
Valabrega, G. .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (05) :638-643
12345